An IHC-derived TLS–CD8–macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC

• by Jingyu Tan, Yan Liu, Binbin Wang, Haiwen Liu

• June 19, 2026

2026 AACR Renal Cell Carcinoma Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

• June 17, 2026

• 1 min

Optical coherence tomography features and visual prognosis in vitreoretinal lymphoma: a structured phenotyping study

• by Xiaona Wang, Dehai Liu, Yingyu Li, Pei Zhang, Hongliang Dou, Hong Qi

• June 17, 2026

Trastuzumab emtansine versus trastuzumab plus pertuzumab for HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world study

• by Zhong Wang, Yimin Zhang, Feng Yao, Jinxin Li, Chenyuan Li, Shichong Liao

• June 18, 2026